PE31195A1 - Derivado de carbazol sustituido, proceso para su preparacion y composicion farmaceutica que lo contiene - Google Patents

Derivado de carbazol sustituido, proceso para su preparacion y composicion farmaceutica que lo contiene

Info

Publication number
PE31195A1
PE31195A1 PE1994255110A PE25511094A PE31195A1 PE 31195 A1 PE31195 A1 PE 31195A1 PE 1994255110 A PE1994255110 A PE 1994255110A PE 25511094 A PE25511094 A PE 25511094A PE 31195 A1 PE31195 A1 PE 31195A1
Authority
PE
Peru
Prior art keywords
preparation
pharmaceutical composition
piridin
ilo
alkyl
Prior art date
Application number
PE1994255110A
Other languages
English (en)
Spanish (es)
Inventor
Peter Clive Cherry
Andrew David Searle
John Derek Cocker
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE31195A1 publication Critical patent/PE31195A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
PE1994255110A 1993-05-21 1994-11-18 Derivado de carbazol sustituido, proceso para su preparacion y composicion farmaceutica que lo contiene PE31195A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310635A GB9310635D0 (en) 1993-05-21 1993-05-21 Chemical compounds

Publications (1)

Publication Number Publication Date
PE31195A1 true PE31195A1 (es) 1995-10-18

Family

ID=10736007

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1994255110A PE31195A1 (es) 1993-05-21 1994-11-18 Derivado de carbazol sustituido, proceso para su preparacion y composicion farmaceutica que lo contiene

Country Status (19)

Country Link
EP (1) EP0699196A1 (fi)
JP (1) JPH08510455A (fi)
CN (1) CN1126473A (fi)
AU (1) AU6928794A (fi)
BG (1) BG100154A (fi)
CA (1) CA2162921A1 (fi)
CZ (1) CZ305195A3 (fi)
FI (1) FI955587A0 (fi)
GB (1) GB9310635D0 (fi)
HU (1) HUT73790A (fi)
IL (1) IL109703A0 (fi)
NO (1) NO954681D0 (fi)
OA (1) OA10195A (fi)
PE (1) PE31195A1 (fi)
PL (1) PL311702A1 (fi)
SK (1) SK142495A3 (fi)
TW (1) TW279866B (fi)
WO (1) WO1994027989A1 (fi)
ZA (1) ZA943494B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0721943A4 (en) * 1993-09-30 1996-09-04 Yamanouchi Pharma Co Ltd AZOLE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
AU3846395A (en) * 1994-11-07 1996-05-31 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
HUP9801158A3 (en) * 1995-03-01 1999-11-29 Yamanouchi Pharma Co Ltd Imidazole derivatives and medicinal composition thereof
DE69810760T2 (de) * 1997-02-21 2003-11-20 Takeda Chemical Industries Ltd Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung
NZ526387A (en) 2000-11-17 2004-02-27 Takeda Chemical Industries Ltd Imidazole derivatives having a steroid C17,20-lyase- inhibitory activity, their production process and use thereof
CA2429437A1 (en) 2000-11-20 2002-05-23 Takeda Chemical Industries, Ltd. Imidazole derivatives, process for their preparation and their use
AU2002221080A1 (en) 2000-12-08 2002-06-18 Masami Kusaka Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparingthe same and use thereof
JP5204650B2 (ja) 2005-06-24 2013-06-05 イーライ リリー アンド カンパニー アンドロゲン受容体調節物質として有用なテトラヒドロカルバゾール誘導体
GB0525323D0 (en) 2005-12-13 2006-01-18 Sterix Ltd Compound
US8093279B2 (en) 2005-12-13 2012-01-10 Gillian Reed, legal representative Compound
CN100586932C (zh) * 2007-01-26 2010-02-03 中国医学科学院医药生物技术研究所 抗肿瘤化合物及其制备方法
EA021011B1 (ru) 2009-06-26 2015-03-31 Новартис Аг 1,3-ДИЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ ИМИДАЗОЛИДИН-2-ОНА В КАЧЕСТВЕ ИНГИБИТОРОВ Cyp 17
EP2531029B1 (en) 2010-02-04 2016-10-19 Radius Health, Inc. Selective androgen receptor modulators
PT2568806T (pt) 2010-05-12 2016-08-05 Radius Health Inc Regimes terapêuticos
KR101823275B1 (ko) 2010-08-04 2018-03-08 펠피큐어 파마슈티걸즈 아이엔씨 전립선 암종의 치료를 위한 병용 요법
EP2627648A1 (en) 2010-09-16 2013-08-21 Novartis AG 17aHYDROXYLASE/C17,20-LYASE INHIBITORS
JP5965909B2 (ja) 2010-09-28 2016-08-10 ラジウス ヘルス,インコーポレイテッド 選択的アンドロゲン受容体モジュレーター
KR20140025492A (ko) 2011-04-28 2014-03-04 노파르티스 아게 17α-히드록실라제/C17,20-리아제 억제제
US9492460B2 (en) * 2013-02-27 2016-11-15 Bristol-Myers Squibb Company Carbazole compounds useful as bromodomain inhibitors
WO2014158875A1 (en) 2013-03-14 2014-10-02 Pellficure Pharmaceuticals Inc. Novel therapy for prostate carcinoma
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
DK3122426T3 (da) 2014-03-28 2023-04-03 Univ Duke Behandling af brystcancer ved anvendelse af selektive østrogenreceptormodulatorer
CA2960750A1 (en) 2014-09-12 2016-03-17 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
KR102397890B1 (ko) 2016-06-22 2022-05-12 일립시스 파마 리미티드 Ar+ 유방암 치료 방법
EP3528799A1 (en) 2016-10-24 2019-08-28 Pellficure Pharmaceuticals, Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione
EP3565542B1 (en) 2017-01-05 2024-04-10 Radius Pharmaceuticals, Inc. Polymorphic forms of rad1901-2hcl

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
CZ305195A3 (en) 1996-06-12
SK142495A3 (en) 1996-06-05
IL109703A0 (en) 1994-08-26
AU6928794A (en) 1994-12-20
HUT73790A (en) 1996-09-30
HU9503321D0 (en) 1996-01-29
FI955587A (fi) 1995-11-20
GB9310635D0 (en) 1993-07-07
CA2162921A1 (en) 1994-12-08
NO954681L (no) 1995-11-20
BG100154A (en) 1996-07-31
OA10195A (en) 1996-12-18
EP0699196A1 (en) 1996-03-06
TW279866B (fi) 1996-07-01
FI955587A0 (fi) 1995-11-20
PL311702A1 (en) 1996-03-04
JPH08510455A (ja) 1996-11-05
NO954681D0 (no) 1995-11-20
CN1126473A (zh) 1996-07-10
WO1994027989A1 (en) 1994-12-08
ZA943494B (en) 1995-01-23

Similar Documents

Publication Publication Date Title
PE31195A1 (es) Derivado de carbazol sustituido, proceso para su preparacion y composicion farmaceutica que lo contiene
GB1289224A (fi)
AR247402A1 (es) Un procedimiento para preparar antibioticos macrolidos c-20 aminosustituidos
Hubert et al. A Novel Reductive Cyclization of Imides
MY123467A (en) Preparation of sterically hindered amine ethers
Elion et al. The direct thiation of uracils
KR890014470A (ko) 카르바펜엠 중간체의 제조방법
DK557281A (da) Fremgangsmaade til indfoering af alkoxy- og aralkyloxygrupper i organiske forbindelser
PE20011078A1 (es) PROCEDIMIENTO DE OBTENCION DE LOS DERIVADOS DE DIBENZO [b, f] AZEPINA
AR246523A1 (es) Procedimiento para preparar acidos 1,3,4,9-tetra-hidropirano¡3,4-b¿indol-1-aceticos sustituidos.
PE20001486A1 (es) Compuestos etereos anular de 7 a 14 miembros como inhibidores de proteasas
ATE22065T1 (de) Alkan- und alkenderivate und ihre herstellung und verwendung.
ES8404679A1 (es) Procedimiento para preparar un derivado de nitroimidazol.
Corey et al. Synthetic imino analogs of Cecropia juvenile hormones as potentiators of juvenile hormone activity
US3968112A (en) Synthesis of penniclavine and elymoclavine
US2606914A (en) delta8(9)14-androstadienes and method of preparing the same
ES2032809T3 (es) Metodo para producir un compuesto de 7-bromo-b-carbolina.
CN114349656B (zh) 一种酰肼类化合物的制备方法
ES2034537T3 (es) Procedimiento para la obtencion de derivados del acido 5-(n-3,4,5,6-tetrahidroftalimido)-canimico.
ES447737A1 (es) Procedimiento para la preparacion de 1,4-benzodiazepinas sustituidas en posicion 2.
MX3153E (es) Procedimiento para la preparacion de 4 - fenil - imidazolinas sustituidas
Barltrop et al. Hydroxypyrylium photochemistry. A new intermediate
ES440831A1 (es) Un procedimiento de obtencion de nuevos acidos bencilamino alcanoicos.
ES272982A1 (es) Un procedimiento de prepaciën de derivados alcohilados en posiciën 2-alfa de la 19 -nortestosterona
US4082753A (en) Penniclavine acetonide

Legal Events

Date Code Title Description
FA Abandonment or withdrawal